Pharmaceutical Technology3 小时
Convidecia by CanSino Biologics for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Convidecia is under clinical development by CanSino Biologics and currently in Phase III for Coronavirus Disease 2019 (COVID-19).